Spyre Therapeutics
SYRE
#2075
Rank
NZ$16.22 B
Marketcap
NZ$170.86
Share price
-4.26%
Change (1 day)
295.47%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2026 (TTM): NZ-$4.91

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$5.13. In 2025 the company made an earnings per share (EPS) of NZ-$3.76 an increase over its 2024 EPS that were of NZ-$6.81.

EPS history for Spyre Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$4.9130.77%
2025NZ-$3.76-44.82%
2024NZ-$6.81